In this article, we will examine the Best Emerging Technology Stocks to Buy Right Now.
While the telephone brought comfort, smartphones changed lives. While factories powered economies, artificial intelligence began rewriting them. Every generation experiences a turning point where technology doesn’t just improve how we live, but also reshapes the foundation of society. Today, we are at such a point.
Emerging technologies, including biotechnology, artificial intelligence, quantum computing, and autonomous systems, are redefining industries at a speed that rivals the Industrial Revolution. These are not incremental improvements, but they are disruptive forces with the potential to unlock new markets worth trillions of dollars. The pace of innovation is accelerating, and its impact reaches far beyond traditional technology companies.
This shift has been visible in financial markets over the last few years. The S&P 500 has been trending higher, with the Nasdaq leading the way as investors increased exposure to technology stocks. Recent gains have been concentrated in companies driving advances in areas like AI, cloud, and biotech, showing that emerging technologies are moving from the edges of the market to its center.
READ ALSO: Best Stocks For Day Trading: 12 Stock Picks and 15 Best Multibagger Stocks to Invest in Right Now.
Market leaders are echoing this sentiment. Kevin Mahn, president and CIO of Hennion & Walsh Asset Management, told CNBC on September 10 that the AI revolution is “alive and well.” He argued that Oracle’s recent results reinforce the momentum behind the AI boom, rather than being a one-off event.
Mahn pointed out that, just as Nvidia’s data center business has surged, Oracle’s cloud division is experiencing rapid growth, indicating that the investment opportunity in AI extends well beyond applications into the infrastructure that powers it.
In its June release, the World Economic Forum’s Top 10 Emerging Technologies of 2025 report underscored how quickly innovation is branching into new fields. Among the advances are structural battery composites that reduce weight while storing energy, biochemical sensors capable of continuous health or environmental monitoring, and watermarking tools designed to authenticate AI-generated content.
Together, as the forum believes, they reflect a future where technology is judged not only by efficiency but also by resilience, sustainability, and trust. While many of these remain in the early stages, they highlight the trajectory of innovation that public and private companies are beginning to commercialize.
Given this backdrop, let’s turn to our selection of the 11 best emerging technology stocks to buy right now.
Copyright: bugphai / 123RF Stock Photo
Our Methodology
To compile our list of best emerging technology stocks to buy, we screened U.S.-listed companies leading in innovative and disruptive technologies through vetting ETFs, industry reports, and online portals. We set a minimum market capitalization threshold of $300 million and required at least 20% potential upside to ensure meaningful growth prospects. From this universe, we selected 11 stocks with the strongest growth prospects (highest upside) and ranked them in ascending order based on their upside potential. We also included data on hedge fund holdings in these companies based on Insider Monkey’s database, as of Q2 2025.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
Note: All pricing data is as of market close on September 12, 2025.
11 Best Emerging Technology Stocks to Buy Right Now
11. CRISPR Therapeutics AG (NASDAQ:CRSP)
Focus Area: Gene editing through CRISPR/Cas9
Market Cap: $5.1 Billion
Potential Upside: 39%
Number of Hedge Fund Holders: 26
CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of America Securities analyst Alec Stranahan reiterated a Buy rating on CRISPR Therapeutics AG (NASDAQ:CRSP) with an unchanged price target of $78.
The rating comes as the company continues to advance its CRISPR/Cas9 gene-editing platform, a breakthrough technology for gene editing that enables precise changes to DNA sequences and directly corrects faulty genes. With a pipeline that spans treatments for blood disorders, cancer, and rare genetic diseases, CRISPR Therapeutics AG (NASDAQ:CRSP) is positioning itself at the forefront of one of the most disruptive innovations in biotechnology.
While still in the early stages of commercialization, the technology’s potential to reshape the treatment landscape is becoming increasingly clear.
That view had also been echoed earlier by H.C. Wainwright analyst Mitchell Kapoor. On August 7, the analyst reiterated a Buy rating and lifted his price target to $80 from $65, citing a 114% quarter-over-quarter increase in CASGEVY sales during Q2 2025.
He pointed to accelerating patient adoption, bolstered by the expansion of 75 authorized treatment centers, as well as CRISPR Therapeutics AG’s (NASDAQ:CRSP) strong cash position that extends its operating runway into 2027.
Kapoor also added projections for CTX310 to his model, estimating peak revenue potential of $4 billion, which further strengthens the long-term growth story.
We can safely say that the combination of analyst conviction, rising sales momentum, and a robust pipeline suggests that CRISPR is beginning to shift from a promise to delivery, offering investors exposure to one of the most compelling stories in emerging biotechnology.
CRISPR Therapeutics AG (NASDAQ:CRSP) is a gene-editing company that is developing transformative therapies using its proprietary CRISPR/Cas9 platform. Its pipeline spans treatments for hemoglobinopathies, oncology, regenerative medicine, and rare genetic diseases.
10. AST SpaceMobile Inc. (NASDAQ:ASTS)
Focus Area: Space-based cellular broadband
Market Cap: $13.9 Billion
Potential Upside: 45%
Number of Hedge Fund Holders: 30
AST SpaceMobile Inc. (NASDAQ:ASTS) is one of the best emerging technology stocks to buy right now. The company is positioning itself as a pioneer in next-generation telecom, developing the first satellite-based broadband network designed to connect directly to standard mobile phones.
By combining satellite technology with existing cellular infrastructure, the company aims to address one of the industry’s most significant gaps in providing affordable, seamless coverage in remote and underserved regions.
The company has tremendous opportunities. AST SpaceMobile Inc. (NASDAQ:ASTS) estimates the 10-year demand for satellite direct-to-device communications at roughly $100 billion, within a global mobile wireless services market exceeding $1 trillion.
With its low-earth orbit (LEO) BlueBird satellite constellation, the company aims to turn that potential into scale, moving closer to commercial rollout.
On September 4, the company disclosed that its first Block 2 BlueBird satellite, BlueBird 6, is now fully assembled and undergoing final tests before shipment. The company also confirmed that 20 satellites have received approval from the Federal Communications Commission for launch, underscoring steady operational progress.
Days later, Scott Searle, an analyst at Roth MKM, reiterated a Buy rating with a $56 price target. Searle’s September 8 note reflects his continued confidence in AST SpaceMobile Inc.’s (NASDAQ:ASTS) ability to deliver on its vision of space-based cellular connectivity.
However, unlike Searle, not all views remain bullish. On September 9, UBS analyst Chris Schoell downgraded the stock to Hold and cut the price target to $43 from $62. Schoell flagged heightened competition following Starlink’s acquisition of Echostar’s S-Band spectrum, which bolsters Starlink’s standing in the space-to-cellular market.
He cautioned that the stronger rival presence raises execution risks for AST SpaceMobile Inc. (NASDAQ:ASTS) and could push carriers to diversify partnerships, thereby challenging AST’s ability to capture market share.
